Crossmark Global Holdings Inc. Sells 4,687 Shares of Cigna Group $CI

Crossmark Global Holdings Inc. trimmed its position in shares of Cigna Group (NYSE:CI) by 3.9% during the third quarter, HoldingsChannel reports. The firm owned 116,050 shares of the health services provider’s stock after selling 4,687 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in Cigna Group were worth $33,451,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in the company. Norges Bank bought a new stake in shares of Cigna Group in the second quarter worth about $1,110,426,000. Arrowstreet Capital Limited Partnership lifted its stake in Cigna Group by 24.4% in the second quarter. Arrowstreet Capital Limited Partnership now owns 2,508,740 shares of the health services provider’s stock valued at $829,339,000 after buying an additional 492,045 shares in the last quarter. Balyasny Asset Management L.P. increased its position in shares of Cigna Group by 1,057.2% during the second quarter. Balyasny Asset Management L.P. now owns 404,753 shares of the health services provider’s stock worth $133,803,000 after acquiring an additional 369,775 shares in the last quarter. Man Group plc raised its holdings in shares of Cigna Group by 215.5% during the second quarter. Man Group plc now owns 532,183 shares of the health services provider’s stock worth $175,929,000 after acquiring an additional 363,510 shares during the period. Finally, Corient Private Wealth LLC raised its holdings in shares of Cigna Group by 257.4% during the second quarter. Corient Private Wealth LLC now owns 389,637 shares of the health services provider’s stock worth $127,811,000 after acquiring an additional 280,616 shares during the period. Institutional investors own 86.99% of the company’s stock.

More Cigna Group News

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Cigna’s credit ratings were affirmed by AM Best (Financial Strength Rating A / Long‑Term ICR “a+”), which reduces balance‑sheet and counterparty concerns for investors. AM Best affirms ratings
• Positive Sentiment: Major sell‑side support remains: Piper Sandler kept an Overweight stance and high price target (small trim), and other analysts continue to highlight Cigna’s growth profile after strong earnings. That provides continued analyst backing for the stock. Piper Sandler price target story
• Positive Sentiment: Cigna reaffirmed its 2026 financial outlook while announcing the CEO succession and elected Brian Evanko to the board — the outlook reaffirmation reduces immediate guidance risk. PR Newswire release
• Positive Sentiment: Cigna raised its quarterly dividend (announced recently), which supports income investors and signals management confidence in cash flow. MarketBeat dividend note
• Neutral Sentiment: Management appearances and investor conference activity (TD Cowen) plus regional PR (awards, interviews) provide investor color but are not immediate stock catalysts. TD Cowen presentation notice
• Neutral Sentiment: Profile/interview pieces on outgoing CEO David Cordani and the company’s long-term strategy add context for investors but are informational rather than catalytic. Courant CEO profile
• Negative Sentiment: The CEO succession (David Cordani to retire July 1; President/COO Brian Evanko to succeed) prompted an initial negative market reaction as investors digested leadership change and execution risk, which was the primary near‑term drag on the stock. Seeking Alpha on leadership transition
• Negative Sentiment: Insider selling (recent filings show officers/directors trimming positions) can amplify near‑term downward pressure or signal liquidity needs; monitor whether sales continue. InsiderTrades alert
• Negative Sentiment: Broader healthcare sector weakness this week is a headwind for CI — sector declines can depress even well‑funded insurers in the short term. Yahoo sector update

Analyst Ratings Changes

CI has been the topic of a number of research reports. Guggenheim restated a “buy” rating and issued a $318.00 price target on shares of Cigna Group in a report on Monday, February 2nd. Truist Financial raised their price target on shares of Cigna Group from $320.00 to $350.00 and gave the stock a “buy” rating in a research note on Tuesday, February 17th. Jefferies Financial Group boosted their price objective on shares of Cigna Group from $310.00 to $333.00 and gave the stock a “buy” rating in a research report on Monday, February 9th. Weiss Ratings restated a “hold (c-)” rating on shares of Cigna Group in a report on Monday, December 29th. Finally, Mizuho set a $325.00 price objective on Cigna Group in a report on Friday, January 9th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, Cigna Group has a consensus rating of “Moderate Buy” and an average price target of $330.42.

Insider Buying and Selling at Cigna Group

In related news, insider Everett Neville sold 1,719 shares of the company’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $496,636.29. Following the transaction, the insider owned 5,670 shares in the company, valued at approximately $1,638,119.70. This represents a 23.26% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Nicole S. Jones sold 2,307 shares of the firm’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the sale, the insider owned 32,647 shares of the company’s stock, valued at $9,432,044.77. This trade represents a 6.60% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.70% of the company’s stock.

Cigna Group Trading Up 0.2%

Shares of NYSE:CI opened at $284.50 on Thursday. Cigna Group has a 52-week low of $239.51 and a 52-week high of $350.00. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.74 and a current ratio of 0.74. The company has a market capitalization of $74.97 billion, a P/E ratio of 12.83, a price-to-earnings-growth ratio of 0.98 and a beta of 0.27. The company has a 50-day simple moving average of $280.68 and a 200 day simple moving average of $284.45.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, topping analysts’ consensus estimates of $7.88 by $0.20. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The firm had revenue of $72.50 billion for the quarter, compared to the consensus estimate of $69.53 billion. During the same quarter in the previous year, the business earned $6.64 earnings per share. The business’s revenue was up 10.4% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Sell-side analysts forecast that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Investors of record on Thursday, March 5th will be paid a $1.56 dividend. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date is Thursday, March 5th. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is currently 27.23%.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.